Production and quality control of cytokine products derived by biotechnological processes

We have adopted this International Scientific Guideline - 3AB3a

Last updated

19 December 2024

Overseas effective date: August 1990

Categories: Biologicals | Active substance

TGA Annotations: Nil

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.
All documents and other content published by the European Medicines Agency (EMA) on this website are under the copyright and other intellectual property rights ownership of the EMA. Please refer to Legal notice | European Medicines Agency for further information.

Product types

Product regulation